5150 CIBOMA/2004–01: a randomised phase III trial assessing adjuvant capecitabine (X) maintenance therapy after standard chemotherapy for triple-negative early breast cancer (EBC)

✍ Scribed by Lluch, A.; Torrecillas, L.; Barrios, C.H.; Bines, J.; Gómez, H.; Getulio, J.; Ruiz-Borrego, M.; De la Haba, J.; Torres, R.; Ruiz, A.

• Book ID: 123601349
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 48 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(09)71042-0